☆ 4.6 Article

Prognostic ability of lung immune prognostic index in limited-stage small cell lung cancer

BMC CANCER (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Immunology

Tumor-associated myeloid cells: diversity and therapeutic targeting

Alberto Mantovani et al.

Summary: Myeloid cells in tumor tissues, including tumor-associated macrophages and tumor-associated neutrophils, play crucial roles in tumor growth and invasion. In recent years, successful therapeutic approaches have been developed and tested in preclinical cancer models, with some strategies reaching clinical trials.

CELLULAR & MOLECULAR IMMUNOLOGY (2021)

添加到收藏夹

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

添加到收藏夹

Article Oncology

A validation study on the lung immune prognostic index for prognostic value in patients with locally advanced non-small cell lung cancer

Tao Zhang et al.

Summary: Baseline lung immune prognostic index (LIPI) may serve as a potential prognostic biomarker for unresectable locally advanced lung cancer, with inferior outcomes in patients with intermediate-poor LIPI. Further prospective studies are needed to validate the potential of LIPI in patients with locally advanced lung cancer.

RADIOTHERAPY AND ONCOLOGY (2021)

添加到收藏夹

Editorial Material Oncology

Reframing recalcitrance for small-cell lung cancer

F. H. Blackhall

ANNALS OF ONCOLOGY (2021)

添加到收藏夹

Article Oncology

Prognostic role of pretreatment lung immune prognostic index in extensive-stage small-cell lung cancer treated with platinum plus etoposide chemotherapy

Weixiang Qi et al.

Summary: The study demonstrated that in ES-SCLC patients receiving first-line platinum plus etoposide chemotherapy, those with a pretreatment LIPI score of 2 had a poorer prognosis compared to those with a LIPI score of 0-1. Further research is recommended to validate these findings in prospective studies.

CANCER BIOMARKERS (2021)

添加到收藏夹

Article Oncology

Prognostic Value of the Pretreatment Lung Immune Prognostic Index in Advanced Small Cell Lung Cancer Patients Treated With First-Line PD-1/PD-L1 Inhibitors Plus Chemotherapy

Lingling Li et al.

Summary: This study showed that pretreatment LIPI can serve as a prognostic biomarker for advanced small cell lung cancer patients receiving first-line PD-1/PD-L1 inhibitors plus chemotherapy, with patients in the LIPI good group demonstrating better survival outcomes.

FRONTIERS IN ONCOLOGY (2021)

添加到收藏夹

Article Oncology

Prognostic factor analysis of patients with small cell lung cancer: Real-world data from 988 patients

Xiangjuan Ma et al.

Summary: This study found that response to primary systemic therapy and aggressive radiotherapy are independent prognostic factors for small cell lung cancer (SCLC) based on large real-world data analysis. In limited stage and extensive stage SCLC, prophylactic cranial irradiation (PCI) and aggressive radiotherapy for original or metastatic sites were shown to improve overall survival.

THORACIC CANCER (2021)

添加到收藏夹

Review Oncology

Systemic immunity in cancer

Kamir J. Hiam-Galvez et al.

Summary: Understanding systemic immune landscape beyond the tumour microenvironment is crucial in assessing the effectiveness of immunotherapy in cancer treatment. Despite the potential of immunotherapy to induce new immune responses, compromised immune responses in individuals with tumors may limit its efficacy.

NATURE REVIEWS CANCER (2021)

添加到收藏夹

Review Immunology

Tumor-infiltrating lymphocytes in the immunotherapy era

Sterre T. Paijens et al.

Summary: The success of cancer immune checkpoint blockade has led to increased interest in tumor-infiltrating lymphocytes (TILs) across different cancer types. Single-cell analysis has revealed high cellular heterogeneity in TILs, with distinct patterns of immune activation and exhaustion. While TIL distributions are similar across tumor types, their responses to immunotherapy vary, highlighting the complexity of tumor-immune interactions.

CELLULAR & MOLECULAR IMMUNOLOGY (2021)

添加到收藏夹

Article Oncology

Lung immune prognostic index as a prognostic factor in patients with small cell lung cancer

Kei Sonehara et al.

THORACIC CANCER (2020)

添加到收藏夹

Review Biochemistry & Molecular Biology

Priming the tumor immune microenvironment with chemo(radio)therapy: A systematic review across tumor types

Tom van den Ende et al.

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2020)

添加到收藏夹

Review Immunology

The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications

Yuanyuan Zhang et al.

CELLULAR & MOLECULAR IMMUNOLOGY (2020)

添加到收藏夹

Article Oncology

Prognostic Value of the Lung Immune Prognostic Index for Patients Treated for Metastatic Non-Small Cell Lung Cancer

Dickran Kazandjian et al.

JAMA ONCOLOGY (2019)

添加到收藏夹

Article Oncology

Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?

Rui-Mei Feng et al.

CANCER COMMUNICATIONS (2019)

添加到收藏夹

Article Oncology

Association of the Lung Immune Prognostic Index With Immune Checkpoint Inhibitor Outcomes in Patients With Advanced Non-Small Cell Lung Cancer

Laura Mezquita et al.

JAMA ONCOLOGY (2018)

添加到收藏夹

Article Oncology

Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial

Corinne Faivre-Finn et al.

LANCET ONCOLOGY (2017)

添加到收藏夹

Review Oncology

Impact of thoracic radiotherapy timing in limited-stage small-cell lung cancer: usefulness of the individual patient data meta-analysisaEuro

D. De Ruysscher et al.

ANNALS OF ONCOLOGY (2016)

添加到收藏夹

Review Oncology

Prognostic significance of serum LDH in small cell lung cancer: A systematic review with meta-analysis

Xiuxiu Zhang et al.

CANCER BIOMARKERS (2016)

添加到收藏夹

Review Oncology

Nomograms in oncology: more than meets the eye

Vinod P. Balachandran et al.

LANCET ONCOLOGY (2015)

添加到收藏夹

Article Oncology

Cigarette Smoking and Variations in Systemic Immune and Inflammation Markers

Meredith S. Shiels et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)

添加到收藏夹

Review Oncology

HIF expression and the role of hypoxic microenvironments within primary tumours as protective sites driving cancer stem cell renewal and metastatic progression

Beatrice Philip et al.

CARCINOGENESIS (2013)

添加到收藏夹

Review Medicine, Research & Experimental

Targeting lactate metabolism for cancer therapeutics

Joanne R. Doherty et al.

JOURNAL OF CLINICAL INVESTIGATION (2013)

添加到收藏夹

Review Biochemistry & Molecular Biology

Microenvironmental regulation of tumor progression and metastasis

Daniela F. Quail et al.

NATURE MEDICINE (2013)

添加到收藏夹

Review Biochemistry & Molecular Biology

Immunity, Inflammation, and Cancer

Sergei I. Grivennikov et al.

CELL (2010)

添加到收藏夹

Review Biochemistry & Molecular Biology

The Warburg effect and mitochondrial stability in cancer cells

Vladimir Gogvadze et al.

MOLECULAR ASPECTS OF MEDICINE (2010)

添加到收藏夹

Article Oncology

Influence of sex on toxicity and treatment outcome in small-cell lung cancer

S Singh et al.

JOURNAL OF CLINICAL ONCOLOGY (2005)

添加到收藏夹

Article Oncology

Systematic review evaluating the timing of thoracic radiation therapy in combined modality therapy for limited-stage small-cell lung cancer

DB Fried et al.

JOURNAL OF CLINICAL ONCOLOGY (2004)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.